Balang, Rosita A.
HRN: 23-52-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/15/2023
08/21/2023
IV
500mg
Q8h
Ameobiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes